argenx
Boston · Founded 2008
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $3.8B
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2023)
- Ticker: ebr:ARGX
- Website: argenx.com
- Phone: 833-274-9411.
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/argenx-33062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.